Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charles Loprinzi

Showing results (1-10 of 67) with videos related to

Pageof 7
Sort By:
Mayo Clinic Women'S Healthsource|August 6, 2004
Follow-up care after breast cancer treatmentCharles Loprinzi
Clinical Breast Cancer|January 21, 2003
Novel approaches to preventing chemotherapy-induced cognitive dysfunction in breast cancer: the art of the possibleDebra Barton, Charles Loprinzi
Journal of Palliative Medicine|April 25, 2006
Antiemetic properties of megestrol acetateCharles Loprinzi, Aminah Jatoi
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|August 11, 2022
Pregabalin for chemotherapy-induced neuropathy: background and rationale for further studyMellar Davis, Charles Loprinzi
The Journal of Supportive Oncology|October 13, 2005
The questions of prognosisCharles Loprinzi, David Steensma
Menopause (New York, N.Y.)|February 21, 2013
Extinguishing hot flash therapyCharles Loprinzi, J Michael Bostwick
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 10, 2005
Physician/patient decision aids for adjuvant therapyTimothy J Whelan, Charles Loprinzi
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 31, 2003
Why not start with thalidomide?Charles Loprinzi, S Vincent Rajkumar
Supportive Cancer Therapy|July 18, 2008
Vitamin e for the prevention of chemotherapy-induced peripheral neuropathy: rationale for an ongoing clinical trialLisa Kottschade, Charles Loprinzi, Ravi Rao
Current Oncology Reports|September 12, 2018
Building a Cardio-Onco-Hematology ProgramJoerg Herrmann, Charles Loprinzi, Kathryn Ruddy
Pageof 7

Showing results (1-10 of 67) with videos related to

Sort By:
Pageof 7
Mayo Clinic Women'S Healthsource|August 6, 2004
Follow-up care after breast cancer treatmentCharles Loprinzi
Clinical Breast Cancer|January 21, 2003
Novel approaches to preventing chemotherapy-induced cognitive dysfunction in breast cancer: the art of the possibleDebra Barton, Charles Loprinzi
Journal of Palliative Medicine|April 25, 2006
Antiemetic properties of megestrol acetateCharles Loprinzi, Aminah Jatoi
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|August 11, 2022
Pregabalin for chemotherapy-induced neuropathy: background and rationale for further studyMellar Davis, Charles Loprinzi
The Journal of Supportive Oncology|October 13, 2005
The questions of prognosisCharles Loprinzi, David Steensma
Menopause (New York, N.Y.)|February 21, 2013
Extinguishing hot flash therapyCharles Loprinzi, J Michael Bostwick
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 10, 2005
Physician/patient decision aids for adjuvant therapyTimothy J Whelan, Charles Loprinzi
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 31, 2003
Why not start with thalidomide?Charles Loprinzi, S Vincent Rajkumar
Supportive Cancer Therapy|July 18, 2008
Vitamin e for the prevention of chemotherapy-induced peripheral neuropathy: rationale for an ongoing clinical trialLisa Kottschade, Charles Loprinzi, Ravi Rao
Current Oncology Reports|September 12, 2018
Building a Cardio-Onco-Hematology ProgramJoerg Herrmann, Charles Loprinzi, Kathryn Ruddy
Pageof 7